{"id":"W3174841530","doi":"10.1038/s41416-021-01415-9","title":"Safety and impact of dose reductions on efficacy in the randomised MONALEESA-2, -3 and -7 trials in hormone receptor-positive, HER2-negative advanced breast cancer","year":2021,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":false,"ca_institutions":"BC Cancer Agency","funders":"Novartis Pharmaceuticals Corporation","keywords":"Breast cancer; Medicine; Oncology; Hormone receptor; Cancer; Internal medicine; Oestrogen receptor; Clinical trial; Hormone","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001188418,0.0001870507,0.00115894,0.0001585302,0.00006318581,0.00003112397,0.00008051106,0.00007683451,0.0002027566],"category_scores_gemma":[0.0007425473,0.0001463536,0.0002316945,0.0004726381,0.0002291118,0.0002357582,0.00001999666,0.0005308268,1.557687e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004439634,"about_ca_system_score_gemma":0.0006084856,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001755574,"about_ca_topic_score_gemma":0.001094065,"domain_scores_codex":[0.9975713,0.0006134402,0.0009903403,0.0002293665,0.000361873,0.000233665],"domain_scores_gemma":[0.9976595,0.001009341,0.0006608432,0.000123024,0.0004231077,0.0001241832],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.1044282,0.0007422061,0.006903409,0.00006705061,0.0008556269,0.0004540421,0.002521452,0.002828301,0.04404943,0.00001644149,0.0002267684,0.836907],"study_design_scores_gemma":[0.06949982,0.0003717647,0.9198782,0.003093616,0.0001590407,0.003004876,0.001011104,0.00000943898,0.002280616,0.0001192014,0.0004269653,0.0001452865],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9453079,0.05045981,0.00001512782,0.002975773,0.0001269694,0.0005888196,0.0004109328,0.000003774524,0.0001108631],"genre_scores_gemma":[0.9345278,0.06447294,0.0003781225,0.0001900757,0.0002902948,0.00004283754,0.000005281851,0.00002398883,0.0000687297],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9129748,"threshold_uncertainty_score":0.5968125,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01697719221813876,"score_gpt":0.3431304860266393,"score_spread":0.3261532938085006,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}